1106 results for Support
Refine Your Search
Sophia
When I was in middle school, my dad was diagnosed with acute lymphoblastic leukemia (ALL). During this time, The Leukemia and Lymphoma Society deeply …
A phase 1 study of AUTX-703, a KAT2A/B degrader, in patients with AML or MDS
In June 2025, LLS made an equity investment in Auron Therapeutics to "Support Clinical Development of AUTX-703 in Relapsed/Refractory AML and MDS."Aur…
Research: TAP
Stupid Cancer
To empower, support, and improve health outcomes for the young adult cancer community Offers CancerCon - an annual 4-day gathering which include…
Janiyah
Our beautiful Janiyah was diagnosed with acute lymphoblastic leukemia (ALL) at 14 months old. Some will say by chance or luck, others say by the grac…
ASCO News - Magrolimab in Combination with Azacitidine Demonstrates Durable Activity in Untreated MDS & AML
May 29, 2020 - FOSTER CITY, Calif. - Gilead Sciences, Inc. (Nasdaq: GILD) today announced updated results from a single-arm, open-label Phase 1b trial…
Understanding your child's health insurance coverage
Health insurance helps pay for costly medical treatment and can protect families from financial hardship. There are different types of private and pub…
Support Resources
Joan
In October 2014, I was handing out candy to my neighborhood’s tiny ghouls and goblins, but the scariest thing that Halloween was a phone call from my …
Myra
At age 2, Myra began having fevers and joint pain. Her parents took her to their pediatrician where she had bloodwork done. The results came back norm…
Krista
Where do I begin? I am a 2x acute myeloid leukemia (AML) survivor diagnosed for the first time in 2008 at the age of 38. My family and I received amaz…
Mollie
Although I was a cancer patient many years ago, survivorship is a journey I take every day. Ever since my diagnosis, I’ve spent my free time engaging …
Peyton
My son, Peyton, was diagnosed with non-Hodgkin lymphoma (NHL) in 2021 when he was just eight years old. I nearly dropped to the ground in devastation …
Dare 2 Dream
Greg
In 2017, our world turned upside down when my father, Greg, was diagnosed with acute myeloid leukemia (AML). The only chance to save his life was a bo…
Resources for Survivors
Survivorship Workbook Use this Survivorship Workbook to collect all the important information you need throughout diagnosis, treatment, follow-up c…
Matthew
In September, 2012, Dr. Matthew Levine noticed that his regular exercise routine and rotations in the ER were more physically draining than usual. Whe…
Kyle
In April 2019, Kyle, a 17-year-old football star at Glenn Hills High School in Hephzibah, Georgia, noticed a large lump on his throat while taking a s…
“Stages” of Leukemia: Understanding Classification and Progression
Table of contentsStages of Leukemia Chronic Lymphocytic Leukemia (CLL) Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Chronic Mye…
Childhood Hodgkin lymphoma
Support Resources
Bold goal, bold action
As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer, the children with blood cancer I have had the honor of…
Alyssa
My story begins with a diagnosis of hypothyroidism but they noticed something unusual with my white blood cell count, which was elevated but I had no …
Choosing a Treatment Center
Selecting a cancer treatment center may depend on several factors including your specific diagnosis, location and insurance coverage. You will want to…
Alison & Keith
This is a love story about two Team In Training honorees, Alison and Keith. Keith has been a recreational runner for many years and first learned of T…
Doug
I have always been a builder. Professionally, I am an architect. You could say that I’ve spent my life building spaces where people could grow. I ne…
Douglas
My story begins almost 24 years ago in 1996, when I was diagnosed with cancer, chronic lymphocytic leukemia (CLL). Back then, there was no cure for CL…
Research Infrastructure to Promote Enrollment of Underserved Patients on Clinical Trials
The goal of the Clinical Trial Network of South Texas is to expand access to high quality clinical trials for under-represented minority (African Amer…
A phase 1/2 study of BI-1206, a monoclonal antibody to CD32b (FcyRIIB), in combination with rituximab in patients with indolent NHL that has relapsed or is refractory to rituximab
In January 2023, LLS made an equity investment in BioInvent to "Support Clinical Development of BI-1206 for NHL Indications and BI-1808 for T-Cell Lym…